In particular, sympathetic nerve endings are modified by diabetes altering either the tissue content or the release of sympathetic co-transmitters noradrenaline (NA), neuropeptide tyrosine (NPY), and ATP (Huidobro-Toro and Donoso, 2004). The gene discussed is NPY; the disease is diabetes mellitus.